Work continues on an Abilify lawsuit settlement agreement which would resolve more than 1,000 claims that the antipsychotic causes gambling addiction and other compulsive behaviors.…
A federal judge has called on parties involved in Abilify gambling lawsuits to begin working on finalizing a global settlement by September.…
The makers of Abilify have agreed to settle three claims that the antipsychotic causes compulsive gambling which were scheduled to go to trial this summer.…
New warnings have been added to the warning label for the antipsychotic Rexulti, warning that it carries a risk of gambling addiction, similar to claims made regarding the drug Abilify.…
A settlement committee will meet with a Special Master on Friday to see if three Abilify gambling lawsuits slated for trial this summer can be resolved before going in front of a jury.…
The FDA warns that Lamictal side effects may cause potentially deadly immune system reactions and has added new label warnings to the drug.…
A new study finds that non-antibiotic drugs may also contribute to the development of drug-resistant bacteria.…
The first three lawsuits of Abilify gambling addiction have been selected for bellwether trials to begin this summer.…
Parties involved in Abilify gambling litigation have failed to agree on the order of the first bellwether trials, leaving it to the Court to decide which way to select the most representative cases.…
A conference being held next week on Abilify gambling litigation may decide if a second round of bellwether trials will be necessary, and whether those trials would involve multiple plaintiffs at once.…
